Going into 2018 you might have expected this to be the year of Alzheimer’s drugs, with several promising trials underway – but unfortunately the last 12 months have been marked by failure a
Digital technology is playing an increasingly important role in healthcare, and in the pharma industry as it searches for ways to find new drugs, while cutting costs and reducing expensive
Oncology drugs are developing at a fast pace, but 2018 was the year when immune-oncology set new standards for several of the most common forms of the disease.
Market access has become a key focus for governments across the globe in 2018 – though as ever a balance between what is good for the industry and what is good for countries and their healt
The trend for working with patients, advocacy groups and appraisal authorities has yielded potentially life-changing results for patient centricity in 2018.